Pramipexole CAS: 104632-26-0
Catalog Number | XD93838 |
Product Name | Pramipexole |
CAS | 104632-26-0 |
Molecular Formula | C10H17N3S |
Molecular Weight | 211.33 |
Storage Details | Ambient |
Product Specification
Appearance | White powder |
Assay | 99% min |
Pramipexole is a medication that belongs to the class of dopamine agonists. It is primarily used to treat symptoms of Parkinson's disease, a chronic neurological disorder characterized by motor impairments such as tremors, stiffness, and difficulties with movement and balance.The main mechanism of action of pramipexole is stimulating dopamine receptors in the brain, specifically the D2 and D3 receptors. Dopamine is a neurotransmitter that plays a crucial role in motor control, cognition, and mood regulation. By activating these receptors, pramipexole helps to compensate for the dopamine deficiency in the brain and improve the motor symptoms associated with Parkinson's disease.Pramipexole can be used as monotherapy in the early stages of Parkinson's disease or in combination with other medications, such as levodopa, to enhance their therapeutic effects. It can help reduce the frequency and severity of motor fluctuations, known as "on-off" episodes, and alleviate the symptoms of stiffness, tremors, and bradykinesia (slowness of movement).In addition to Parkinson's disease, pramipexole has also been found to be effective in the treatment of restless legs syndrome (RLS). RLS is a neurological disorder characterized by an irresistible urge to move the legs, often accompanied by uncomfortable sensations. Pramipexole provides relief by reducing these restless leg symptoms, allowing for improved sleep quality.The dosage and administration of pramipexole will vary depending on the individual patient's requirements and response to treatment. The medication is typically taken orally, and the dosage may need to be adjusted by a healthcare professional to find the most effective and tolerable dose.As with any medication, pramipexole may cause side effects. Common side effects include nausea, dizziness, drowsiness, and constipation. These symptoms are usually mild and improve with continued use or dose adjustment. However, it is important to report any severe or persistent side effects to a healthcare professional.In conclusion, pramipexole is a dopamine agonist used primarily in the treatment of Parkinson's disease and restless legs syndrome. By stimulating dopamine receptors in the brain, it helps improve motor symptoms associated with Parkinson's disease and alleviate symptoms of restless legs syndrome. Close monitoring and dose adjustment by a healthcare professional are important to ensure the safe and effective use of pramipexole.